SI-BONE Statistics
Total Valuation
SI-BONE has a market cap or net worth of $817.80 million. The enterprise value is $719.09 million.
| Market Cap | 817.80M |
| Enterprise Value | 719.09M |
Important Dates
The last earnings date was Monday, August 3, 2026, after market close.
| Earnings Date | Aug 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SI-BONE has 44.35 million shares outstanding. The number of shares has increased by 3.80% in one year.
| Current Share Class | 44.35M |
| Shares Outstanding | 44.35M |
| Shares Change (YoY) | +3.80% |
| Shares Change (QoQ) | +1.18% |
| Owned by Insiders (%) | 3.54% |
| Owned by Institutions (%) | 106.53% |
| Float | 42.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.85 |
| Forward PS | 3.27 |
| PB Ratio | 4.50 |
| P/TBV Ratio | 4.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 438.76 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.15, with a Debt / Equity ratio of 0.23.
| Current Ratio | 9.15 |
| Quick Ratio | 7.37 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.13 |
Financial Efficiency
Return on equity (ROE) is -8.30% and return on invested capital (ROIC) is -5.13%.
| Return on Equity (ROE) | -8.30% |
| Return on Assets (ROA) | -4.62% |
| Return on Invested Capital (ROIC) | -5.13% |
| Return on Capital Employed (ROCE) | -7.90% |
| Weighted Average Cost of Capital (WACC) | 7.92% |
| Revenue Per Employee | $568,093 |
| Profits Per Employee | -$38,915 |
| Employee Count | 376 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 1.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.61% in the last 52 weeks. The beta is 0.70, so SI-BONE's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +6.61% |
| 50-Day Moving Average | 16.31 |
| 200-Day Moving Average | 16.03 |
| Relative Strength Index (RSI) | 63.20 |
| Average Volume (20 Days) | 553,498 |
Short Selling Information
The latest short interest is 5.51 million, so 12.42% of the outstanding shares have been sold short.
| Short Interest | 5.51M |
| Short Previous Month | 5.98M |
| Short % of Shares Out | 12.42% |
| Short % of Float | 12.87% |
| Short Ratio (days to cover) | 8.27 |
Income Statement
In the last 12 months, SI-BONE had revenue of $213.60 million and -$14.63 million in losses. Loss per share was -$0.33.
| Revenue | 213.60M |
| Gross Profit | 169.87M |
| Operating Income | -17.75M |
| Pretax Income | -14.63M |
| Net Income | -14.63M |
| EBITDA | -17.75M |
| EBIT | -17.75M |
| Loss Per Share | -$0.33 |
Balance Sheet
The company has $145.94 million in cash and $42.80 million in debt, with a net cash position of $103.15 million or $2.33 per share.
| Cash & Cash Equivalents | 145.94M |
| Total Debt | 42.80M |
| Net Cash | 103.15M |
| Net Cash Per Share | $2.33 |
| Equity (Book Value) | 182.35M |
| Book Value Per Share | 4.10 |
| Working Capital | 195.87M |
Cash Flow
In the last 12 months, operating cash flow was $1.87 million and capital expenditures -$7.42 million, giving a free cash flow of -$5.55 million.
| Operating Cash Flow | 1.87M |
| Capital Expenditures | -7.42M |
| Depreciation & Amortization | 6.36M |
| Net Borrowing | n/a |
| Free Cash Flow | -5.55M |
| FCF Per Share | -$0.13 |
Margins
Gross margin is 79.53%, with operating and profit margins of -8.31% and -6.85%.
| Gross Margin | 79.53% |
| Operating Margin | -8.31% |
| Pretax Margin | -6.85% |
| Profit Margin | -6.85% |
| EBITDA Margin | -8.31% |
| EBIT Margin | -8.31% |
| FCF Margin | n/a |
Dividends & Yields
SI-BONE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.80% |
| Shareholder Yield | n/a |
| Earnings Yield | -1.78% |
| FCF Yield | -0.67% |
Analyst Forecast
The average price target for SI-BONE is $25.00, which is 35.58% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.00 |
| Price Target Difference | 35.58% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 15.55% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SI-BONE has an Altman Z-Score of 5.25 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.25 |
| Piotroski F-Score | 5 |